Amy C. Peterson, CMO, Immuno-oncology at BeiGene, Ltd. (BGNE), sold 10,141 shares at $132.70 ($1.4M) on 2018-12-18, disclosed to the SEC on 2018-12-19.
Open-market sale of $1.4M BGNE by CMO, Immuno-oncology. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $131.74 | 1,631 | $215K | 15.8% |
| 2 | $132.70 | 1,897 | $252K | 18.6% |
| 3 | $133.88 | 2,402 | $322K | 23.7% |
| 4 | $134.81 | 3,600 | $485K | 35.8% |
| 5 | $135.54 | 611 | $83K | 6.1% |
| Total | $133.75 avg | 10,141 |
| $1.4M |
| 100% |
| Filing → |
| CTMX | SELL | 2022-07-21 | $11K | — | Filing → |
| BGNE | SELL | 2018-12-19 | $4.5M | — | Filing → |
| BGNE | SELL | 2018-12-19 | $1.1M | — | Filing → |